Michael Gould to Comorbidity
This is a "connection" page, showing publications Michael Gould has written about Comorbidity.
Connection Strength
0.615
-
Burden of Comorbid Conditions Among Individuals Screened for Lung Cancer. JAMA Health Forum. 2025 Feb 07; 6(2):e245581.
Score: 0.207
-
Comorbidity Profiles and Their Effect on Treatment Selection and Survival among Patients with Lung Cancer. Ann Am Thorac Soc. 2017 Oct; 14(10):1571-1580.
Score: 0.124
-
An Official American Thoracic Society Workshop Report. A Framework for Addressing Multimorbidity in Clinical Practice Guidelines for Pulmonary Disease, Critical Illness, and Sleep Disorders. Ann Am Thorac Soc. 2016 Mar; 13(3):S12-21.
Score: 0.111
-
The benefits and harms of adjuvant chemotherapy for non-small cell lung cancer in patients with major comorbidities: A simulation study. PLoS One. 2022; 17(11):e0263911.
Score: 0.044
-
Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Use and COVID-19 Infection Among 824 650 Patients With Hypertension From a US Integrated Healthcare System. J Am Heart Assoc. 2021 02 02; 10(3):e019669.
Score: 0.039
-
Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis. Blood. 2020 05 14; 135(20):1788-1810.
Score: 0.037
-
Screening and prevention of venous thromboembolism in critically ill patients: a decision analysis and economic evaluation. Am J Respir Crit Care Med. 2011 Dec 01; 184(11):1289-98.
Score: 0.020
-
Length of stay predictions: improvements through the use of automated laboratory and comorbidity variables. Med Care. 2010 Aug; 48(8):739-44.
Score: 0.019
-
Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives. Health Qual Life Outcomes. 2005 Oct 07; 3:61.
Score: 0.014